Toronto Dominion Bank
RVMD icon

Toronto Dominion Bank’s Revolution Medicines RVMD Stock Holding History

Toronto Dominion Bank’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.12M Buy
21,999
+3,608
+20% +$527K ﹤0.01% 996
2026
Q1 		$1.79M Buy
18,391
+18,377
+131,264% +$1.86M ﹤0.01% 1183
2025
Q4 		$1.11K Buy
+14
New +$918 ﹤0.01% 1929

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Toronto Dominion Bank's RVMD Position: Q2 2026 in Review

Toronto Dominion Bank increased its Revolution Medicines (RVMD) stake by 20% in Q2 2026, buying an estimated $527K and bringing the position to 21,999 shares worth $4.12M. The position accounts for ﹤0.01% of the portfolio, ranked #996.

Toronto Dominion Bank first reported a position in RVMD in Q4 2025 and has held it in 3 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Toronto Dominion Bank held 21,999 shares of Revolution Medicines worth $4.12M as of Q2 2026.
  • Toronto Dominion Bank bought 3,608 Revolution Medicines shares in Q2 2026, an estimated $527K.
  • Revolution Medicines made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #996 holding.
  • Toronto Dominion Bank first reported a position in Revolution Medicines in Q4 2025 and has held it in 3 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.